Search Cancer Clinical Trials

Mass General Cancer Center offers patients access to a wide variety of clinical trials of promising new therapies. Use the search tool to find open protocols for your type of cancer.
Search by condition
Search By:
16 results
  • Sarcoma, Prostate Cancer, Pancreatic Cancer, Lung Cancer, Kidney Cancer, Gastric (Stomach) Cancer, Endometrial Cancer, Colorectal Cancer, Cervical Cancer, Breast Cancer, Bladder Cancer

23-392          Phase I

A Phase 1a/1b, Dose-Escalation/Dose-Expansion study of NPX267 in Subjects with Solid Tumors Known to Express HHLA-2

  • Melanoma, Lung Cancer, Liver Cancer, Head and Neck Cancer, Endometrial Cancer, Colorectal Cancer, Bladder Cancer

24-203          Phase I

An Open-Label Study of GV20-0251 in Patients with Advanced and/or Refractory Solid Tumor Malignancies

  • Endometrial Cancer, Bladder Cancer

22-660          Phase I

An Open-Label, Multicenter Study of LOXO-435 (LY3866288) in Advanced Solid Tumor Malignancies with FGFR3 Alterations

  • Bladder Cancer

21-348          N/A

Bladder fiducial markers and multiparametric-MRI (mp-MRI) to optimize bladder chemo-radiotherapy

  • Bladder Cancer, Breast Cancer, Melanoma, Lung Cancer, Head and Neck Cancer, Colorectal Cancer

22-405          Phase II

Phase 1/2 Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants with Advanced Solid Tumors

  • Bladder Cancer

20-614          Phase I

Sacituzumab govitecan plus enfortumab vedotin for metastatic urothelial carcinoma progressing on platinum-based chemotherapy and PD1/L1 inhibitors: the Double Antibody Drug conjugate (DAD) Phase I trial

Showing 11 - 16 of 16 results